NIH-funded research R21 grant

Using bacteriophages to treat infections from orthopedic devices

Official title: Treatment of Multidrug-Resistant Staphylococcus aureus Orthopaedic-Device Related Biofilm Infections with Local Delivery of Lytic Bacteriophage

Funded at University of Texas Hlth Sci Ctr Houston · NIH-10794979 · Data updated 2026-11-12

This study is exploring a new way to help people with tough infections from orthopedic devices by using special viruses that can kill the bacteria causing the problem, making treatment easier and more effective for those dealing with bone infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startFebruary 22, 2023
Project endJanuary 31, 2026
Funding year2024
Award (this year)$230,279
NIH project number5R21AI176067-02
Project IDNIH-10794979 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients undergoing orthopedic surgeries who are at risk of developing infections due to multidrug-resistant bacteria.

Less likely to help

Patients with infections not related to orthopedic devices or those who do not have multidrug-resistant bacterial infections may not benefit from this research.

What this research studies

This research investigates a new approach to treat infections caused by multidrug-resistant bacteria associated with orthopedic devices. It focuses on using lytic bacteriophages, which are viruses that specifically target and kill bacteria, delivered locally to the site of infection. The goal is to improve treatment outcomes for patients suffering from osteomyelitis related to orthopedic device infections, which are often resistant to traditional antibiotics. By utilizing biodegradable microspheres for delivery, the research aims to provide a more effective and less invasive treatment option.

Why it matters

Potential benefit: If successful, this research could significantly reduce the need for prolonged antibiotic treatments and multiple surgeries for patients with orthopedic device-related infections.

How similar studies have gone: While the use of bacteriophages for treating infections is a promising area of research, this specific approach targeting orthopedic device-related infections is relatively novel and has not been extensively tested.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Kaplan, Heidi B — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Kaplan, Heidi B

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.